These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34443600)

  • 1. Tributyltin(IV) Butyrate: A Novel Epigenetic Modifier with ER Stress- and Apoptosis-Inducing Properties in Colon Cancer Cells.
    Giuliano M; Pellerito C; Celesia A; Fiore T; Emanuele S
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, chemical characterization and biological activity of new histone acetylation/deacetylation specific inhibitors: a novel and potential approach to cancer therapy.
    Pellerito O; Prinzivalli C; Foresti E; Sabatino P; Abbate M; Casella G; Fiore T; Scopelliti M; Pellerito C; Giuliano M; Grasso G; Pellerito L
    J Inorg Biochem; 2013 Aug; 125():16-25. PubMed ID: 23685346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tributyltin(IV) ferulate, a novel synthetic ferulic acid derivative, induces autophagic cell death in colon cancer cells: From chemical synthesis to biochemical effects.
    Pellerito C; Emanuele S; Ferrante F; Celesia A; Giuliano M; Fiore T
    J Inorg Biochem; 2020 Apr; 205():110999. PubMed ID: 31986423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ROS-Dependent ER Stress and Autophagy Mediate the Anti-Tumor Effects of Tributyltin (IV) Ferulate in Colon Cancer Cells.
    Celesia A; Morana O; Fiore T; Pellerito C; D'Anneo A; Lauricella M; Carlisi D; De Blasio A; Calvaruso G; Giuliano M; Emanuele S
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors.
    McBain JA; Eastman A; Nobel CS; Mueller GC
    Biochem Pharmacol; 1997 May; 53(9):1357-68. PubMed ID: 9214697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and evaluation of Cd[L-proline]
    Chidambaram A; Sekar A; S H K; Chidambaram RK; Arunachalam K; G P S; Vilwanathan R
    Invest New Drugs; 2017 Dec; 35(6):691-705. PubMed ID: 28776290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: synthesis, structure, biological efficacy and QSAR studies.
    Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Pellerito C; Singh P; Verma P; Duthie A; de Vos D; Verma RP; Englert U
    J Inorg Biochem; 2010 Sep; 104(9):950-66. PubMed ID: 20553814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of butyrate analogues in HT-29 cancer cells.
    Ooi CC; Good NM; Williams DB; Lewanowitsch T; Cosgrove LJ; Lockett TJ; Head RJ
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):482-9. PubMed ID: 19930426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis for histone acetylation of human colon cancer cells treated with a novel HDAC inhibitor.
    Zhao Y; Fang X; Wang Y; Zhang J; Jiang S; Liu Z; Ma Z; Xu L; Li E; Zhang K
    Curr Pharm Des; 2014; 20(11):1866-73. PubMed ID: 23888955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of
    Halaburková A; Jendželovský R; Kovaľ J; Herceg Z; Fedoročko P; Ghantous A
    Clin Epigenetics; 2017; 9():62. PubMed ID: 28603560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of potential pathways involved in induction of apoptosis by butyrate and 4-benzoylbutyrate in HT29 colorectal cancer cells.
    Fung KY; Ooi CC; Lewanowitsch T; Tan S; Tan HT; Lim TK; Lin Q; Williams DB; Lockett TJ; Cosgrove LJ; Chung MC; Head RJ
    J Proteome Res; 2012 Dec; 11(12):6019-29. PubMed ID: 23057685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone proteins determined in a human colon cancer by high-performance liquid chromatography and mass spectrometry.
    Naldi M; Andrisano V; Fiori J; Calonghi N; Pagnotta E; Parolin C; Pieraccini G; Masotti L
    J Chromatogr A; 2006 Sep; 1129(1):73-81. PubMed ID: 16887128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation.
    Hinnebusch BF; Meng S; Wu JT; Archer SY; Hodin RA
    J Nutr; 2002 May; 132(5):1012-7. PubMed ID: 11983830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An appraisal of cinnamyl sulfonamide hydroxamate derivatives (HDAC inhibitors) for anti-cancer, anti-angiogenic and anti-metastatic activities in human cancer cells.
    Reddy ND; Shoja MH; Biswas S; Nayak PG; Kumar N; Rao CM
    Chem Biol Interact; 2016 Jun; 253():112-24. PubMed ID: 27163855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biphenyl-4-yl-acrylohydroxamic acids: Identification of a novel indolyl-substituted HDAC inhibitor with antitumor activity.
    Cincinelli R; Zwick V; Musso L; Zuco V; De Cesare M; Zunino F; Simoes-Pires C; Nurisso A; Giannini G; Cuendet M; Dallavalle S
    Eur J Med Chem; 2016 Apr; 112():99-105. PubMed ID: 26890116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
    Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
    Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
    Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
    Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological Evaluation of Triorganotin Derivatives as Potential Anticancer Agents.
    Stefanizzi V; Minutolo A; Valletta E; Carlini M; Cordero FM; Ranzenigo A; Prete SP; Cicero DO; Pitti E; Petrella G; Matteucci C; Marino-Merlo F; Mastino A; Macchi B
    Molecules; 2023 May; 28(9):. PubMed ID: 37175265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects.
    Miao JF; Peng YF; Chen S; Gao WJ; Yang QX; Zhu P; Guo J; Tao J; Luo L; Zhang Y; Ling Y
    Eur J Pharmacol; 2018 Apr; 824():78-88. PubMed ID: 29428472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.